Clinical trial
Efficacy and Safety Oral Contraceptive Study
NCT00185484 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00185484 |
|---|---|
| Title | Efficacy and Safety Oral Contraceptive Study |
| Official title | Multi-center, Open, Uncontrolled Study to Investigate the Efficacy and Safety of the Oral Contraceptive SH T 186 D Containing 0.02 mg Ethinylestradiol-b-cyclodextrin Clathrate and 3 mg Drospirenone in a 24-day Regimen for 13 Cycles in 1010 Healthy Female Volunteers |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300) |
| Enrollment | 1,113 |
| Start date | Mar 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 31, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: